What do the data say about emerging agents for the treatment of nonmetastatic castration-resistant prostate cancer in men who have rapidly rising PSA levels?

Robert Dreicer, MD, on therapeutic advances in prostate cancer.

Learn more on this topic: Therapeutic Advances in Prostate Cancer

Related Material

What are the best ways to manage the toxicities of current and emerging treatments for advanced prostate cancer?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.